Cornell Assessment of Pediatric Delirium (CAPD) in 28 Week Old

The Cornell Assessment of Pediatric Delirium is a rapid observational screening tool that identifies delirium in infants, including those born at 28 weeks’ gestation.

Makes eye contact with caregiver (holds gaze, prefers primary parent, looks at speaker)
Always0Often+1Sometimes+2Rarely+3Never+4
Actions are purposeful (reaches with coordinated smooth movement)
Always0Often+1Sometimes+2Rarely+3Never+4
Aware of surroundings (strongly prefers mother, then other familiars, differentiates between novel and familiar objects)
Always0Often+1Sometimes+2Rarely+3Never+4
Communicates needs and wants (vocalizes/indicates about needs)
Always0Often+1Sometimes+2Rarely+3Never+4
Restless (no sustained calm state)
Never0Rarely+1Sometimes+2Often+3Always+4
Inconsolable (not soothed by usual methods, e.g. singing, holding, talking)
Never0Rarely+1Sometimes+2Often+3Always+4
Underactive (very little movement while awake)
Never0Rarely+1Sometimes+2Often+3Always+4
Takes long time to respond to interactions (not babbling or smiling/laughing in social interactions)
Never0Rarely+1Sometimes+2Often+3Always+4

Indications for Use

Used to screen for delirium in preterm and term infants from birth through 21 years, including extremely preterm infants (≈28 weeks PMA). Detects hypoactive, hyperactive, and mixed delirium within <2 min and is validated in preverbal populations with high sensitivity (≈94%) 1 [Level II evidence]. Particularly useful for routine ICU monitoring and early identification of neurologic deterioration such as evolving critical illness or ICANS 2 [Level II evidence].

Insights & Cautions

Detects delirium in preverbal infants but accuracy is unproven in 28‑week preterm neonates; existing validation focuses on older PICU infants, with strong sensitivity/specificity only in that group 1 [Level III evidence]. Use cautiously in extreme prematurity because neuromotor immaturity, baseline hypoactivity, and variable arousal may mimic scoring abnormalities. Treat results as screening only, requiring bedside clinical confirmation.